Levetiracetam in the treatment of epilepsy - Wikidata - awgldk - TriplyDB

Levetiracetam in the treatment of epilepsy

Levetiracetam in the treatment of epilepsy

http://www.wikidata.org/entity/Q24656333

about

Safety of Levetiracetam in Paediatrics: A Systematic Review A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patients Child development following in utero exposure: levetiracetam vs sodium valproate.Clinical experience with generic levetiracetam in people with epilepsy.Levetiracetam rectal administration in healthy dogs.Levetiracetam Extended Release as Adjuvant Therapy for the Control of Partial-onset Seizures.Levetiracetam mitigates doxorubicin-induced DNA and synaptic damage in neurons Antiepileptic drug use in a nursing home setting: a retrospective study in older adults.Transitional polytherapy: tricks of the trade for monotherapy to monotherapy AED conversions.An Analytical Study to Correlate Serum Levels of Levetiracetam with Clinical Course in Patients with Epilepsy Presentation of Epilepsy in a Patient with Wilson's Disease and Developmental Venous Anomaly (Venous Angioma) in the Brain Efficacy and safety of levetiracetam in pediatric epilepsy.Levetiracetam use in the critical care setting.Advances in management of neonatal seizures.Can Matching-Adjusted Indirect Comparison Methods Mitigate Placebo Response Differences Among Patient Populations in Adjunctive Trials of Brivaracetam and Levetiracetam?Evaluation of brivaracetam: a new drug to treat epilepsy.Levetiracetam for seizure prevention in brain tumor patients: a systematic review.Antiepileptic drug therapy and recommendations for withdrawal in patients with seizures and epilepsy due to neurocysticercosis.Eosinophilia and Fever with Levetiracetam: A Case Report.Levetiracetam induced encephalopathy in a patient with normal renal function: An unusual clinical encounter.Efficacy and Tolerability of Second and Third Generation Anti-epileptic Drugs in Refractory Epilepsy: A Network Meta-Analysis.The anti-ictogenic effects of levetiracetam are mirrored by interictal spiking and high-frequency oscillation changes in a model of temporal lobe epilepsy.Examining the clinical utility of lacosamide: pooled analyses of three phase II/III clinical trials.Levetiracetam induced acute reversible psychosis in a patient with uncontrolled seizures.Two cases of cluster headache effectively treated with levetiracetam.Advances in Pharmacotherapy Development: Human Clinical Studies.Comparative Effectiveness of Levetiracetam vs Phenobarbital for Infantile Epilepsy.Efficacy of mGlu2 -positive allosteric modulators alone and in combination with levetiracetam in the mouse 6 Hz model of psychomotor seizures.Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex.Safety of Overnight Switch from Brand-Name to Generic Levetiracetam.Levetiracetam exhibits protective properties on rat Schwann cells in vitro.

P2860

Q26765160-39740892-B984-4FCA-86AD-545E447F7E78 Q30417813-D9EFB026-358F-4EBB-9566-5C60AEB396ED Q35731533-FD7CBB3F-0486-4250-80C0-1616C3C44BFF Q35845438-AB09329E-2746-4D38-B1C7-C7C568E674C9 Q36873335-87C92A47-79D1-4AF7-AE8E-4F62B909DAA5 Q36873888-982D6D2E-F8BB-48DB-AED8-D6F5314260DE Q36890652-E5F93064-9A3C-428C-92AC-B14ADF2E69B8 Q37074898-B2218F58-DA46-4CDA-8123-B4B636282011 Q37313452-89EFBC33-ECAA-4990-A79F-E07E3D2152C0 Q37593001-C3A32F17-DBAF-47DA-9B90-DB454C4E4F3F Q38070404-AC1E3F0C-F73A-42D2-96AE-CEE58EDF1DFC Q38130230-79894046-90C6-460A-A1A1-C5F0CFF8068F Q38132386-F627ADA0-63FC-4481-A6BF-FDA5D9023371 Q38209366-CFC244DC-0001-40B6-BF44-4E5F14F063EA Q38600989-80499D01-D9D7-4DDE-8982-887B6DCE3941 Q38652806-4BCD623D-7183-4A89-B73F-9FEED6BC01BF Q38832059-DA66E018-BE59-472D-B0A4-F951E89E8691 Q38844933-99759E6B-5BA3-48A4-9332-483402E83399 Q40144866-90AECA2E-8722-4C17-AA9B-EF15B61E443A Q41762766-B1A280B1-CC75-4642-BEBC-C5602A7C2516 Q42113049-48E0004D-7432-40D7-82B6-4161EF1A312E Q42177284-B5CA2ADE-E6EB-4586-82D1-912F59E4888E Q42797086-EBE36444-498E-4E6C-9700-A7812B50DE2E Q42916638-3AE34094-117F-4787-BF5A-3B47D8835D82 Q42928452-C54DA51F-7A3D-409B-AC6D-BEBAECF974CB Q47182010-2D2DE980-2109-426E-B82A-CE0051997D37 Q50045642-C72BC13B-7B73-49E0-8662-90620BE58C03 Q51150507-A1E15910-8882-4CE2-B831-BACF6B3DE515 Q51438384-78D53889-FB47-49BA-B015-F3AD972FD9CB Q52664925-147CA2B4-6D17-43EA-A5C2-257242C89DAD Q54343673-57E3A52E-60E2-436E-80D5-F746A25FDDB1

P2860

Levetiracetam in the treatment of epilepsy

http://www.wikidata.org/entity/Q24656333

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Levetiracetam in the treatment of epilepsy

@ast

Levetiracetam in the treatment of epilepsy

@en

Levetiracetam in the treatment of epilepsy

@nl

type

label

Levetiracetam in the treatment of epilepsy

@ast

Levetiracetam in the treatment of epilepsy

@en

Levetiracetam in the treatment of epilepsy

@nl

prefLabel

Levetiracetam in the treatment of epilepsy

@ast

Levetiracetam in the treatment of epilepsy

@en

Levetiracetam in the treatment of epilepsy

@nl

P1433

Q24656333-5C71E0EC-DE41-44C5-B3E3-71160E427A82

P1476

Q24656333-88E153C6-E919-4DEE-92DD-F4159813D7D6

P2093

Q24656333-BA95804A-9AA6-4C42-953F-EDF577D067B4

P2860

Q24656333-02FA632F-61FA-4E25-B3BE-76EC45F776C1

Q24656333-056270AD-F559-4D96-B873-58797A1037C4

Q24656333-0648B775-8E03-4544-8E1A-6C14161178F3

Q24656333-078754A8-80FA-48CC-B432-FF7233B9F544

Q24656333-07E7BBD5-E385-49F9-B4D0-0CFF8B3026BA

Q24656333-086A70D7-4160-4A50-AAFA-F27F5620522E

Q24656333-08A34C8F-699E-4AAD-98F1-7A5388FA9BAD

Q24656333-0ABAC2E2-4927-42F5-9179-BB3D226ED89B

Q24656333-0AD3722D-E006-4E8E-BAA2-C287054AA003

Q24656333-0C6056D3-0D96-4964-8684-3C8FAC36597C

P304

Q24656333-14C91D97-43C5-44A5-90EF-C0409017E7C1

P31

Q24656333-75E1CEFB-7AE6-49A6-A9E8-18B073DFC169

P3181

Q24656333-A29DF5B1-CEF9-4166-9D9C-C25442034DAD

P356

Q24656333-446BCA11-016D-4E2B-8672-F268230E933B

P407

Q24656333-4A62A7C9-7519-44DC-B4BD-25617E2644FF

P433

Q24656333-C2768342-7094-4D30-A1C7-E210DE474288

P478

Q24656333-75E5B37D-725C-4D2B-8595-B03F54F4B907

P577

Q24656333-1BB15F94-0FA8-40AF-B2F3-3E1A8FEAD3FA

P5875

Q24656333-F988CA0B-DFA4-4266-8427-C73A9D650A37

P698

Q24656333-E24F9DAB-83FE-4B69-8741-5A2545876909

P932

Q24656333-DC2346EE-EBCD-463C-B7E0-D2E73EDE656D

P3181

P356

P1433

Neuropsychiatric Disease and Treatment

P1476

Levetiracetam in the treatment of epilepsy

@en

P2093

Bassel Abou-Khalil

http://www.w3.org/2001/XMLSchema#string

P2860

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

Early identification of refractory epilepsy

A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology

Selective blockade of N-type calcium channels by levetiracetam

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy

Levetiracetam therapy in patients with brain tumour and epilepsy.

The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents

Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review.

Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials.

P304

507-23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1721385

http://www.w3.org/2001/XMLSchema#string

P356

10.2147/NDT.S2937

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23295080

http://www.w3.org/2001/XMLSchema#string

P698

18830435

http://www.w3.org/2001/XMLSchema#string

P932

2526377

http://www.w3.org/2001/XMLSchema#string